APRILBIO CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,160 KRW | +0.86% |
|
+1.07% | -10.03% |
| Sales 2023 | - | Sales 2024 * | 22.5B 16.31M | Capitalization | 329B 239M |
|---|---|---|---|---|---|
| Net income 2023 | -14B -10.15M | Net income 2024 * | -10B -7.25M | EV / Sales 2023 | - |
| Net cash position 2023 * | 85B 61.62M | Net cash position 2024 * | 82B 59.45M | EV / Sales 2024 * | 11 x |
| P/E ratio 2023 |
-22.9
x | P/E ratio 2024 * |
-33.3
x | Employees | - |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 69.14% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.86% | ||
| 1 week | +1.07% | ||
| Current month | -7.39% | ||
| 1 month | -7.39% | ||
| 3 months | +12.88% | ||
| 6 months | +40.37% | ||
| Current year | -10.03% |
1 week
14 800.00
15 600.00
1 month
13 670.0017 450.00
Current year
11 510.0019 150.00
1 year
9 115.0019 150.00
3 years
5 200.0019 150.00
5 years
5 200.0019 150.00
10 years
5 200.0019 150.00
| Managers | Title | Age | Since |
|---|---|---|---|
Sang-Hun Cha
FOU | Founder | 61 | 13-02-11 |
Jin-Taek Kim
DFI | Director of Finance/CFO | 53 | - |
Moo-Young Song
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sang-Hun Cha
FOU | Founder | 61 | 13-02-11 |
Jin-Taek Kim
DFI | Director of Finance/CFO | 53 | - |
Eun-Jik Lee
BRD | Director/Board Member | 65 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-29 | 15,160 | +0.86% | 113,539 |
| 24-04-26 | 15,030 | +0.20% | 112,242 |
| 24-04-25 | 15,000 | -2.53% | 153,038 |
| 24-04-24 | 15,390 | -0.39% | 206,256 |
| 24-04-23 | 15,450 | +3.00% | 334,584 |
End-of-day quote Korea S.E., April 28, 2024
More quotes
AprilBio Co Ltd is a Korea-based company primarily engaged in the biological drug development business. The Company is primarily engaged in the bio-innovative new drug research and development (R&D) business such as antibody therapeutics and long-acting recombinant protein pharmaceuticals.
Calendar
2024-05-09
- Q1 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
15,160
KRW
Average target price
27,000
KRW
Spread / Average Target
+78.10%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.03% | 239M | |
| -2.63% | 102B | |
| +1.62% | 96.29B | |
| +2.53% | 22.18B | |
| -16.67% | 21.2B | |
| -9.19% | 18.31B | |
| -38.74% | 17.38B | |
| -13.21% | 16.36B | |
| +5.41% | 13.97B | |
| +33.57% | 12.17B |
- Stock Market
- Equities
- A397030 Stock
